Sawtooth Solutions, LLC Biogen Inc. Transaction History

Sawtooth Solutions, LLC

$3.64 Billion
Q4 2023

A detailed history of Sawtooth Solutions, LLC transactions in Biogen Inc. stock. As of the latest transaction made, Sawtooth Solutions, LLC holds 2,291 shares of BIIB stock, worth $398,152. This represents 0.02% of its overall portfolio holdings.

Number of Shares

2,291

Previous 2,021 13.36%

Holding current value

$398,152

Previous $519,000 14.07%

% of portfolio

0.02%

Previous 0.02%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 29, 2024	BUY	$222.59 - $267.94 $60,099 - $72,343	270 Added 13.36%	2,291 $592,000
Q3 2023 Oct 19, 2023	SELL	$253.3 - $285.89 $157,805 - $178,109	-623 Reduced 23.56%	2,021 $519,000
Q2 2023 Jul 26, 2023	BUY	$275.25 - $318.06 $27,525 - $31,806	100 Added 3.93%	2,644 $753,000
Q1 2023 Apr 27, 2023	BUY	$256.56 - $292.34 $136,489 - $155,524	532 Added 26.44%	2,544 $707,000
Q4 2022 Feb 02, 2023	BUY	$252.44 - $306.72 $218,108 - $265,006	864 Added 75.26%	2,012 $557,000
Q3 2022 Oct 12, 2022	BUY	$194.69 - $268.46 $5,061 - $6,979	26 Added 2.32%	1,148 $307,000
Q2 2022 Jul 19, 2022	BUY	$187.54 - $223.02 $210,419 - $250,228	1,122 New	1,122 $229,000
Q4 2021 Feb 11, 2022	SELL	$223.92 - $287.77 $162,565 - $208,921	-726 Closed	0 $0
Q3 2021 Nov 09, 2021	BUY	$282.99 - $369.05 $23,205 - $30,262	82 Added 12.73%	726 $205,000
Q2 2021 Sep 01, 2021	BUY	$259.0 - $414.71 $166,796 - $267,073	644 New	644 $223,000
Q1 2021 May 13, 2021	SELL	$242.95 - $284.63 $1.65 Million - $1.93 Million	-6,785 Closed	0 $0
Q4 2020 Feb 09, 2021	SELL	$236.26 - $355.63 $980,242 - $1.48 Million	-4,149 Reduced 37.95%	6,785 $1.66 Million
Q3 2020 Nov 04, 2020	BUY	$264.77 - $305.71 $1.16 Million - $1.34 Million	4,369 Added 66.55%	10,934 $3.1 Million
Q2 2020 Aug 06, 2020	BUY	$258.66 - $342.55 $1.32 Million - $1.75 Million	5,105 Added 349.66%	6,565 $1.76 Million
Q1 2020 May 15, 2020	SELL	$268.85 - $341.04 $30,111 - $38,196	-112 Reduced 7.12%	1,460 $462,000
Q4 2019 Feb 12, 2020	BUY	$220.06 - $304.07 $116,191 - $160,548	528 Added 50.57%	1,572 $466,000
Q3 2019 Nov 07, 2019	SELL	$217.44 - $243.88 $447,926 - $502,392	-2,060 Reduced 66.37%	1,044 $243,000
Q2 2019 Aug 08, 2019	BUY	$219.29 - $241.72 $481,780 - $531,058	2,197 Added 242.23%	3,104 $726,000
Q1 2019 May 10, 2019	BUY	$216.71 - $338.96 $196,555 - $307,436	907 New	907 $214,000
Q4 2018 Feb 13, 2019	SELL	$278.5 - $352.75 $170,999 - $216,588	-614 Closed	0 $0
Q3 2018 Oct 26, 2018	BUY	$293.51 - $383.83 $180,215 - $235,671	614 New	614 $217,000

Others Institutions Holding BIIB

# of Institutions

1,018

Shares Held

128M

Call Options Held

1.22M

Put Options Held

1.4M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sawtooth Solutions, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sawtooth Solutions, LLC with notifications on news.

Account

Sawtooth Solutions, LLC Biogen Inc. Transaction History